Insider selling
Traded Nov 29, 2024 · filed 4 days laterNot reported under a pre-arranged trading plan
The CFO of Filana Therapeutics sold $7.6K of Filana Therapeutics shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
From a 13F filed Feb 14, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Reduced
Compared with the manager's Q3 2024 13F
97,051
37,998
−60.8%
Share count drives classification; reported value also moves with price
0.30%
Within the filing's reported positions, not the manager's total assets
1
For Q4 2024
Insider selling
Traded Nov 29, 2024 · filed 4 days laterNot reported under a pre-arranged trading plan
The CFO of Filana Therapeutics sold $7.6K of Filana Therapeutics shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 29, 2024 · filed 4 days laterNot reported under a pre-arranged trading plan
The CFO of Filana Therapeutics sold $231K of Filana Therapeutics shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 29, 2024 · filed 4 days laterNot reported under a pre-arranged trading plan
Filana Therapeutics's Chief Medical Officer sold $15K of Filana Therapeutics shares. The filing does not indicate a pre-arranged trading plan.